Use of multiple biomarkers for a molecular diagnosis of prostate cancer
Open Access
- 17 December 2004
- journal article
- early detection-and-diagnosis
- Published by Wiley in International Journal of Cancer
- Vol. 114 (6), 950-956
- https://doi.org/10.1002/ijc.20760
Abstract
The identification of biomarkers capable of providing a reliable molecular diagnostic test for prostate cancer (PCa) is highly desirable clinically. We describe here 4 biomarkers, UDP‐N‐Acetyl‐α‐D‐galactosamine transferase (GalNAc‐T3; not previously associated with PCa), PSMA, Hepsin and DD3/PCA3, which, in combination, distinguish prostate cancer from benign prostate hyperplasia (BPH). GalNAc‐T3 was identified as overexpressed in PCa tissues by microarray analysis, confirmed by quantitative real‐time PCR and shown immunohistochemically to be localised to prostate epithelial cells with higher expression in malignant cells. Real‐time quantitative PCR analysis across 21 PCa and 34 BPH tissues showed 4.6‐fold overexpression of GalNAc‐T3 (p = 0.005). The noncoding mRNA (DD3/PCA3) was overexpressed 140‐fold (p = 0.007) in the cancer samples compared to BPH tissues. Hepsin was overexpressed 21‐fold (p = 0.049, whereas the overexpression for PSMA was 66‐fold (p = 0.047). When the gene expression data for these 4 biomarkers was combined in a logistic regression model, a predictive index was obtained that distinguished 100% of the PCa samples from all of the BPH samples. Therefore, combining these genes in a real‐time PCR assay represents a powerful new approach to diagnosing PCa by molecular profiling. (Supplemental material for this article can be found on the International Journal of Cancer website at http://www.interscience.wiley.com/jpages/0020‐7136/suppmat/index.html.)This publication has 34 references indexed in Scilit:
- Third International Conference on Innovations and Challenges in Prostate Cancer: Prevention, Detection and TreatmentJournal of Urology, 2003
- Combining biomarkers to detect disease with application to prostate cancerBiostatistics, 2003
- Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissuesThe Prostate, 2003
- Expression analysis of δ‐catenin and prostate‐specific membrane antigen: Their potential as diagnostic markers for prostate cancerInternational Journal of Cancer, 2002
- Delineation of prognostic biomarkers in prostate cancerNature, 2001
- Association of HPC2/ELAC2 Genotypes and Prostate CancerAmerican Journal of Human Genetics, 2000
- Detailed methylation analysis of the glutathione S-transferase π (GSTP1) gene in prostate cancerOncogene, 1999
- cDNA Cloning and Expression of a Novel Human UDP- -acetyl-α-D-galactosaminePublished by Elsevier BV ,1996
- The Lack of Predictive Value of Prostate Specific Antigen Density in the Detection of Prostate Cancer in Patients with Normal Rectal Examinations and Intermediate Prostate Specific Antigen LevelsJournal of Urology, 1995
- UROLOGICAL TUMOURS: RECENT CHANGESAnz Journal of Surgery, 1995